Cheryl H. Arrowsmith

Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8

Kyle V. Butler, S. Frye, W. Janzen, 2014, Journal of medicinal chemistry.

Identification of lysine isobutyrylation as a new histone modification mark

C. Arrowsmith, Yingming Zhao, Y. G. Zheng, 2020, bioRxiv.

Optimization of resolution and sensitivity of 4D NOESY using Multi-dimensional Decomposition

V. Orekhov, C. Arrowsmith, A. Yee, 2005, Journal of biomolecular NMR.

Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.

S. Frye, C. Arrowsmith, M. Vedadi, 2011, Journal of medicinal chemistry.

A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3).

Xi-Ping Huang, B. Roth, P. Atadja, 2015, Angewandte Chemie.

ChemRAP uncovers specific mRNA translation regulation via RNA 5′ phospho-methylation

Nathan S. Abell, Blerta Xhemalçe, Sravan K Devanathan, 2024, EMBO reports.

Revealing the protein propionylation activity of the histone acetyltransferase MOF (males absent on the first)

C. Arrowsmith, Yingming Zhao, Xiang-Jiao Yang, 2018, The Journal of Biological Chemistry.

HMCES Functions in the Alternative End-Joining Pathway of the DNA DSB Repair during Class Switch Recombination in B Cells.

L. Aravind, C. Arrowsmith, A. Rao, 2019, Molecular cell.